Response to Comments: Osteogenesis Stimulators - DL33796

This document reports that during the 45-day public comment period for Osteogenesis Stimulators (Feb 9–Mar 25, 2023) no comments were received. No coverage criteria, limitations, documentation requirements, or frequency limits are provided or changed in this response-to-comments document.